TEVA - Investor Relations (IR) - Investor Relations Home

News

May 14, 2013

Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

May 08, 2013

Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.

May 02, 2013

Teva Reports First Quarter 2013 Results

Webcasts and Presentations

May 2013

Calendar Help

This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.

Calendar Icon Legend:

Analyst Meeting

Conference

Conference Presentation

Corporate Conference Call

Custom Events

Earnings Conference Call

Earnings Release

Financial Reports

Mergers & Acquisition Announcement

Guidance Announcement

Other Corporate

Sales Call/Presentation

Sales Release

Shareholders Meeting

News Release

SEC Filings

Presentations

52 Week High

‹

Today

›

Sun

Mon

Tue

Wed

Thu

Fri

Sat

-3

-2

-1

May 01, 2013

6-K

Formats:

May 02, 2013

Q1 2013 Teva Pharmaceutical Industries Ltd Earnings Conference Call

Teva Reports First Quarter 2013 Results

6-K

Formats:

6-K

Formats:

May 06, 2013

6-K

Formats:

May 08, 2013

Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.

6-K

Formats:

May 10, 2013

6-K

Formats:

May 14, 2013

Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

May 15, 2013

2:20 p.m. PT

Teva Pharmaceutical Industries Ltd at Bank of America Merrill Lynch Health Care Conference

Financial Information

Financial Fundamentals

Quarterly and Annual Reports

Debt

SEC Filings

Investor Kit

You can quickly assemble your own Investor Kit by selecting and printing the following documents. To order printed materials, or request additional investor-related information, complete an information request.